Protembis, a privately-held emerging cardiovascular medical device company, announced today the establishment of a Scientific Advisory Board (SAB) to provide objective advice and contribute to the strategic plans of the company. Specifically, the SAB will provide overarching scientific and clinical strategic guidance, advise on emerging trends and opportunities, and provide expert counsel on scientific and clinical matters. This press release features multimedia. View the full release here: htt...

Fujirebio Europe today announced the availability* of the INNO-LiPA HCV 2.0 Genotyping assay. The product, previously distributed by Siemens Healthcare Diagnostics Inc. under the name VERSANT HCV Genotype 2.0, is a line probe assay, for in vitro diagnostic use, designed for the qualitative detection and identification of Hepatitis C virus (HCV) genotypes 1 to 6 and subtypes a and b of genotype 1 in human serum or EDTA plasma samples. Additional subtype information is available in a majority of ...

Dubai Chambers will host the Dubai Business Forum – Germany in Hamburg on 20 May 2025. Organised by Dubai Chambers with Hamburg Chamber of Commerce as Supporting Partner, the forum is set to further strengthen trade and investment relations between Germany and Dubai. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250320266403/en/H.E. Mohammad Ali Rashed Lootah, President & CEO of Dubai Chambers (Photo: AETOSWire) Building on the ...

Pioneering medical technology company Xenco Medical has once again been named one of the World’s Most Innovative Companies by Fast Company Magazine. The esteemed annual list recognizes renowned companies whose groundbreaking technologies are ushering in transformative change. Xenco Medical was previously named one of the World’s Most Innovative Companies by Fast Company in 2023. As the recipient of the honor once again in 2025, Xenco Medical joins a rare group of transformational companies name...